Recovering Fraudulent Claims for Australian Federal Expenditure on Pharmaceuticals and Medical Devices

Thomas Faunce, Gregor URBAS, Lesley Ann Skillen, Marc Smith

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

The Australian Federal Government expends increasingly large amounts of money on pharmaceuticals and medical devices. It is likely, given government experience in other jurisdictions, that a significant proportion of this expenditure is paid as a result of fraudulent claims presented by corporations. In the United States, legislation such as the False Claims Act 1986 (US), the Fraud Enforcement and Recovery Act 2009 (US), the Stark (Physician Self-Referral) Statute 1995 (US), the Anti-Kickback Statute 1972 (US), the Food, Drug and Cosmetic Act 1938 (US), the Social Security Act 1965 (US), and the Patient Protection and Affordable Care Act 2010 (US) has created systematic processes allowing the United States Federal Government to recover billions of dollars in fraudulently made claims in the health and procurement areas. The crucial component involves the creation of financial incentives for information about fraud to be revealed from within the corporate sector to the appropriate state officials. This article explores the opportunities for creating a similar system in Australia in the health care setting.
Original languageEnglish
Pages (from-to)302-315
Number of pages14
JournalJournal of Law and Medicine
Volume18
Issue number2
Publication statusPublished - 2010

Fingerprint

Dive into the research topics of 'Recovering Fraudulent Claims for Australian Federal Expenditure on Pharmaceuticals and Medical Devices'. Together they form a unique fingerprint.

Cite this